Medical Pharmacology Chapter 36: Antiviral Drugs
Antiviral Drugs
Anti-viral drugs with activity against HIV (Human Immunodeficiency Virus)
Viral Transmission2
|
HIV is mainly transmitted by sexual contact (both heterosexual and male to male); by blood and blood products and by infected mothers to infants (intrapartum, perinatally or by means of breast milk). No evidence exists suggesting that HIV may be transmitted by casual contact or that the virus can be spread by insects (e.g. mosquito bite).2
HIV infection is mainly an STD (sexually transmitted disease) worldwide.
The most common infection mode, especially in developing countries, is heterosexual transmission.
In many Western countries, an increase in incidence of male-to-male sexual transmission has developed.
The likelihood of heterosexual HIV transmission is influenced by viral load as well as by presence of ulcerative genital diseases; however heterosexual transmission is usually inefficient.
A major study considered 174 monogamous couples in which one partner was HIV-1 positive.
The study involved a population in Rakai, Uganda.
Intercourse frequency and reporting reliability within couples were evaluated prospectively.
HIV-1 seroconversion was determined in uninfected partners.
HIV-1 viral load was measured in infected partners. Rates of HIV-1 transmission per coital was determined.
The study reported that the mean intercourse frequency was 8.9 per month, declining both with age and HIV-1 viral load.
Members of couples reported comparable intercourse frequencies.
The overall unadjusted likelihood of HIV-1 transmission per coital act was 0.0011 i.e. about 0.11%.
The transmission likelihood increased from about 0.01% per act and viral loads less than 1700 viral copies/ml to 0.23% per coital act at 38,500 copies/ml or more.
A higher likelihood of transmission per coital act was noted if genital ulcer disease was present in the HIV-1 positive partner (0.41% vs 0.11%.)
|
|
The presence of HIV in seminal fluids within infected mononuclear cells and in cell-free material has been shown.2
Viral concentration in the seminal fluid appears enhanced under circumstances associated with increased lymphocyte and monocyte number in the fluid.
Urethritis and epididymitis, seen with other sexually transmitted diseases as well, represent such circumstances.2
An increased risk of HIV transmission has been associated with unprotected receptive anal intercourse (URAI), affecting both men and women when compared to the risk associated with receptive vaginal intercourse.2
A tentative estimate of the "per-act" risk for HIV transmission associated with URAI is about 1.5% for men and women (review/meta-analysis).2
HIV acquisition risk due to URAI is likely higher than that seen in penile-vaginal intercourse as a result of a thin, fragile rectal mucosal membrane, separating deposited semen from susceptible cells in and beneath the mucosa.
Another factor may be the trauma of anal intercourse.
Anal douching and sexual practices which traumatize the rectal mucosa increase the infection probability.
Anal intercourse may be associated with at least two infection modalities.
(1) Inoculation into blood, directly, because of mucosal traumatic tears.
(2) Presence of susceptible target cells, including Langerhans cells, in the mucosal layer.
|
|
Despite the vaginal mucosal structure being several layers thicker than rectal mucosa and accordingly more resistant to being traumatized during intercourse, the HIV-1 virus may be transmitted to either partner during vaginal intercourse.
Clinical studies suggest that male-to female HIV transmission is likely more efficient than female-to-male transmission.
Such differences may be due to longer seminal fluid vaginal-cervical mucosal exposure.
On the other hand, the penis and urethral orifice are exposed only briefly to infected vaginal fluid.2
Cofactors which have been examined as possibly affecting heterosexual HIV transmission include concurrent infection with other STDs.2
This cofactor appears strongly associated with HIV transmission.
As suggested earlier, a close association between genital ulcerations and transmission has been identified.
This association may be due both to susceptibility to infection and infectivity.
Causes of genital ulcerations associated with HIV transmission include infections with Treponoma pallidum, Haemophilus ducreyi, and herpes simplex virus (HSV).2
|
|
|
|
|
|
Other pathogens that cause nonulcerative inflammatory sexually transmitted diseases are also associated with elevated HIV transmission infection risk.
Examples of these pathogens include:
Chlamydia trachomatis
|
Neisseria gonorrhoeae
|
|
Trichomonas vaginalis
|
|
Oral Sex:2
Oral sex is considered a significantly less efficient transmission mode of HIV compared to anal intercourse or vaginal intercourse.
Given reports of documented HIV transmission as a result of oral sex, any assumption that oral sex is completely safe is not supported.2
HIV transmission risk and drug use:2
HIV transmission risk appears also increased when associated with alcohol consumption, illicit drug use combined with unsafe heterosexual and homosexual behavior.
Taking certain drugs such as methamphetamine as well as other "so-called club drugs"-e.g., ecstasy, ketamine, gamma hydroxybutyrate, possibly in conjunction with phosphodiesterase-5 inhibitors (e.g. sildenafil (Viagra), tadalafil (Cialis) or vardenafil (Levitra) appears associated with risky sexual practices and attendant elevated HIV infection risk (particularly in male-to-male sex).2
|
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |